NISHIMURA Yu | Department of Pathology, Saitama Cancer Center
スポンサーリンク
概要
Department of Pathology, Saitama Cancer Center | 論文
- Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)
- Issues in the Assessment of the Pathologic Effect of Primary Systemic Therapy for Breast Cancer
- Evaluation of interobserver agreement in scoring immunohistochemical results of HER-2/neu (c-erbB-2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinoma
- Evaluation of HER2 Status: For the Treatment of Metastatic Breast Cancers by Humanized Anti-HER2 Monoclonal Antibody (Trastuzumab) (Pathological Committee for Optimal Use of Trastuzumab)
- Recurrence after Sentinel Lymph Node Biopsy With or Without Axillary Lymph Node Dissection in Patients with Breast Cancer